Objectives: To investigate whether congenital renal vein anomalies are involved in the etiology of hematuria by analyzing abdominal multidetector computed tomography (MDCT) results. Methods: Six hundred and eighty patients undergoing MDCT for various abdominal pathologies in whom possible causes of hematuria were excluded were retrospectively assessed in terms of left renal vein anomalies, such as circumaortic left renal vein (CLRV), retroaortic left renal vein (RLRV) and multiple renal vein (MRV). Patients with CLRV, RLRV or MRV and patients with normal left renal veins were compared in terms of the presence of hematuria. Results: Left renal vein anomalies were detected in 100 patients (14.7%). RLRV, CLRV and MRV were identified in 5.4, 2.5 and 6.8% of patients, respectively. Hematuria was determined in 8.1% of patients with an RLRV anomaly and in 10.5% of patients with no RLRV anomaly (p = 0.633). Hematuria was detected in 23.5% of patients with a CLRV anomaly and 10.1% of those without (p = 0.074), and in 21.7% of patients with an MRV anomaly and 9.6% of those without (p = 0.009). Conclusions: In addition to increasing risk of complication during retroperitoneal surgery, numeric congenital renal vein anomalies are also significant in terms of leading to clinical symptoms such as hematuria.

Keywords:
Computed tomography, Congenital renal vein anomalies, Hematuria
1.
Satyapal KS, Kalideen JM, Haffejee AA, et al: Left renal vein variations. Surg Radiol Anat 1999;21:77-81.
2.
Koc Z, Ulusan S, Oguzkurt L: Association of left renal vein variations and pelvic varices in abdominal MDCT. Eur Radiol 2007;17:1267-1274.
3.
Eren S, Yalcın A, Okur A: The use of multi detector computed tomography in assessing the retroaortic left renal vein and accompanying vessel anomalies. EAJM 2010;42:12-14.
4.
Poyraz AK, Firdolas F, Onur MR, et al: Evaluation of left renal vein entrapment using multidetector computed tomography. Acta Radiologica 2013;54:144-148.
5.
Waseem M, Upadhyay R, Prosper G: The nutcracker syndrome: an underrecognized cause of hematuria. Eur J Pediatr 2012;171:1269-1271.
6.
Ozel A, Tufaner O, Kaya E, et al: US and MDCT diagnosis of a rare cause of haematuria in children: posterior nutcracker syndrome. J Ultrasound 2011;14:89-91.
7.
Karaman B, Koplay M, Ozturk E, et al: Retroaortic left renal vein: multidetector computed tomography angiography findings and its clinical importance. Acta Radiol 2007;48:355-360.
8.
Gibo M, Onitsuka H: Retroaortic left renal vein with hypertension causing hematuria. Clin Imaging 1998;22:422-424.
9.
Mathews R, Smith PA, Fishman EK, et al: Anomalies of the inferior vena cava and renal veins: embryologic and surgical considerations. Urology 1999;53:873-880.
10.
Dilli A, Ayaz UY, Kaplanoglu H, et al: Evaluation of the left renal vein variations and inferior vena cava variations by means of helical computed tomography. Clin Imaging 2013;37:530-535.
11.
Cohen RA, Brown RS: Microscopic hematuria. N Engl J Med 2003;348:2330-2338.
12.
Tatar I, Tore HG, Celik HH, et al: Retroaortic and circumaortic left renal veins with their CT findings and review of the literature. Anatomy 2008;2:72-76.
13.
Alper F, Tasar M, Yildiz H, et al: Unexplained hematuria in association with a rare renal vein anomaly: MDCT and MRA demonstration. Cardiovasc Intervent Radiol 2005;28:847-849.
14.
Yesildag A, Adanur E, Koroglu M, et al: Rutin abdomen BT'de sol renal ven anomalilerinin görülme sikliği. Tani Girisim Radyol 2004;10:140-143.
15.
Trigaux JP, Vandroogenbroek S, De Wispelaere JF, et al: Congenital anomalies of the inferior vena cava and left renal vein: evaluation with spiral CT. J Vasc Interv Radiol 1998;9:339-345.
16.
Arslan H, Etlik O, Ceylan K, et al: Incidence of retro-aortic left renal vein and its relationship with varicocele. Eur Radiol 2005;15:1717-1720.
17.
Karazincir S, Balci A, Görür S, et al: Incidence of the retroaortic left renal vein in patients with varicocele. J Ultrasound Med 2007;26:601-604.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.